It ios true LEDs are the wave of the future much like cars were not so long ago. At the time Henry Ford founded his company there were dozens of other companies manufacturing cars. Ford is the sole survivor.
Why will EFOI be the one?
Merry Christmas and Happy New Year to all.
I was invited to post here and give my comments.
I am also currently and regrettably long.
There are a number of places one can go to graph the the price versus volume of the company. This chart and the lack of volume indicate to me there is not much "tax loss" selling going on.
Tinkerbell!!!! You are back. Dollar cost averaging since May. ROFLMAO. aren't you driving looking in the review mirror? It is a shame that Yahoo has decide to let posters delete their own posts. iI allows gas bags to delete their pumping from late February like it never happened.
The fact is Biolase is now 10% for the month and the year and down 20% from it's 2014 high and down 60% from it's 2013 high.
The question is, "What is Biolase worth?" I say between $2 and $2.50 right now, depending on how much cash they burned in 4Q14
Cramer pump Henry Schein and a bunch of techy type dental equipment companies on his show Monday, but failed to mention Biolase. When Biolase cut the cord with Schein in September of 2010 , Schein's stock was selling in the $50s. It is $138 as I write AND Cramer is pumping it to go much higher.
Biolase ran to the $6.30s in just a few month after, never to return. If one had sold their Biolase for the quick triple and then bought and held Schein, one would have seen a 10 bagger.
In hind sight it is obvious whcih of the partners was holding the other back.
I underastand the concept of tax loss selling, but I am disappointed in your lack of understanding of the EFOI situation. There is a LARGE chunk of stock that was converted from bonds in August at a considerable profit for the bond holding friends of Jimmy Tu. More that 1/2 of them filed to sell shares and it is this overhang that others have been claiming as the reason for the price being held back.
If one charts the year to date pricing for EFOI against the volume per price one will see that although the average price paid is ~$6/share since the split the price prior to split is less well less than $5.
The really low volumes indicate a lack of interest more than any tax consideration.
I'm afraid you have it reversed. If you are selling in December for a gain, you'll have to pay taxes in April, 2015. If you wait till January 2nd, you don't have to pay till April 2016. Why would the price be held down, by people not selling to lock up their profit?
I'm afraid your memory is failing you. I have been trading around my core position, buying in the high $7s and low $8s and selling in the high $9s when support failed. I bought my first stock in spring of 2013 playing the arbitrage between PBTH and OPK and wound up keeping a decent chunk of it based on teh Dr. Frost and the compelling story.
I always thought it was a stock for 2015 when FDA approvals are given. Remember when freddie bragged about taking only $1 for being CEO at BIOL?. Dr. Frost has bought HUNDREDS of THOUSANDS of OPK shares on the open market. The good doctor has demonstrated he has the interest of the stockholders at heart since he is the largest one.
Any one of the three drugs in the pipeline could earn $1/share for the company, driving the stock price up to the $20s and $30 in 2016.
OPK closed at $9.33 yesterday. They announced a deal with Pfizer remove any doubts about them being able to fund their MASSIVE pipeline of drugs getting ready to be released after FDA approval.
This is an example of a speculative growth company. It has:
1. Proven top leadership, Dr. Frost has built and sold two companies before for HUGE profits for investors
2. Insider buying. Dr. Frost has been buying an average of 2 or 3 times a WEEK for years. He now controls almost 1/2 of the outstanding shares.
3. Open markets. The company has a dozen drugs in the pipeline with 3 completing phase 3 trials and lloking to get FDA approval in 2015.
The stock is up $1 this quarter, but is a fraction of what it will be worth in 2016, assuming the pipeline is the hit analyst expect it to be.
The Yahoo board is a waste land of mindless pumping and bashing. But has lots of information if you sift through the trash.
There is a huge short position, so not everyone is convinced.
OPK closed at $9.33 yesterday. They announced a deal with Pfizer remove any doubts about them being able to fund their MASSIVE pipeline of drugs getting ready to be released. looks like truthbetold nailed the bottom but didn't buy more like I did.
One needs to understand the story and how it relates to the real world.
In the same period BIOL is unchanged. One has to ask, "What is the likelihood of the new regime being able to drag BIOL to profitability?"
The $295 M up front fee is not all that pricey when one considers the drugs potential and the sunk cost of development without the risk of failure.
iI looks win win to me. OPK gets cash and is set to fund the final phase of it drug pipeline; the benefit of Pizer's sales force; and future royalties.
Gotta love the Doc and his deals. Get a little cash up front and sign up for BIG cash later.
Didn't EVERY board long figure out "... the large upfront payment removes near-term financing needs as an overhang on the stock." YESTERDAY! He must read the board.
The question is short term versus long term. In the short term the Navy orders will make some money and keep the lights on, but in the long run, professionals understand the market is limited.
EFOI "tubes" are already on 15% of the Navy's ships. Since they are "bullet proof" and are assumed to be good for 50,000 hours of operation, there will be little on going replacement once the total conversion is complete. The "tubes" are a short term solution and will not be used on new ships. New ships will be provided with LED fixtures designed for the application.
I'd hoped there would be more "Irrational exuberance" on the news, but I was too greedy. The hope for me is Jimmy Tu will preannounce 4Q14 earning were POSITIVE and the announcement triggers the "Irrational exuberance" hope for.
There is also another thought. Jimmy Tu's team may have let the news leak and that was the cause of last weeks price rise.
I think everyone already discounted the Navy contract into its price. The question is, "What is the margin of the Navy sales?
Everyone that was following EFOI knew about the Navy contracts. No surprise pop. I am surprised about the drop though. I suppose there were a few sell orders in and the low volume of buyers is the answer. I know I had my order in, but it didn't get there. Too greedy I guess.
The cash infusion removes the possible need for a secondary offering. i.e. no fear of dilution till the pipeline becomes profitable.